Cardiopulmonary bypass surgery (CPB) is associated with a high incidence of immunoglobulin G (IgG) antibodies against platelet factor 4/heparin (PF4/H) complexes by day 6 after surgery. These antibodies are associated with an immune-mediated adverse drug reaction, heparin-induced thrombocytopenia. While the early onset of anti-PF4/H IgG response is compatible with a secondary immune response, the rapid decline of antibody titers thereafter is not. To shed light on the origin of these antibodies, we prospectively compared their kinetics to that of antibodies against two recall antigens and to that of autoantibodies in 166 CPB patients over four months. Surgery induced strong inflammation as shown by an increase of the mean C-reactive protein levels. Consistent with previous studies, anti-PF4/H-IgG OD transiently increased between baseline and day 10 (p<0.001; not associated with CRP levels), followed by a decrease over the next months. In contrast, concentrations of anti-diphtheria toxin IgG and anti-tetanus toxin IgG constantly increased over the four months after surgery by 25-30%. IgG autoantibodies did not change. Thus the transient kinetics of the anti-PF4/HIgG response resembled neither that of recall antibodies nor that of IgG autoantibodies, but rather shows a unique profile.
Introduction
HIT shows features of a secondary immune response, of an autoimmune response, and it might be part of a general activation of a host defense system triggered by inflammation. On the other hand, anti-PF4/H antibody titers typically decrease rapidly, 3, 14 even though a secondary immune response should lead to persisting high titers of IgG antibodies.
Anti-PF4/H IgG antibodies are generated in about 50% of patients undergoing cardiopulmonary bypass surgery (CPB). Besides necessitating the administration of heparin for anticoagulation during extracorporeal circulation, CPB poses a substantial challenge to the immune system due to mechanical tissue damage, anesthesia and other medication, extensive contact with foreign surfaces and ischemia-reperfusion injury to tissues. Together, these induce strong inflammation with rapid increase of serum cytokines, such as IL6, IL8, TNFα, and IL10. [15] [16] [17] [18] This situation provided us with the opportunity to investigate whether the anti-PF4/H IgG response after CPB is part of (i) a general disinhibition of autoreactive B cells (general loss of tolerance) and/or (ii) associated with polyclonal activation of memory B cells against recall antigens.
19-22
We followed CPB patients prospectively for more than four months after surgery in order to compare the kinetics of the anti-PF4/H IgG response with that of antibodies targeting other autoantigens as well as antibodies specific for the recall antigens tetanus toxoid (TT) and diphtheria toxin (DT). Our results clearly show that the kinetics of the anti-PF4/H antibody response has a unique profile: Its rapid but transient increase was distinct from that of the antibody response to the recall antigens TT and DT, which gradually increased over the whole observation period without showing the decrease in titers typically observed for anti-PF4/H antibodies. Neither was it part of a general break in tolerance since an increase in the titer of antibodies directed against other typical autoantigens was not observed.
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Patients and Methods
Patients had been enrolled in a previously reported, prospective study in adult patients requiring CPB surgery. [23] [24] [25] From these patients serum samples had been collected before surgery and on days three and ten after surgery. At discharge from hospital, patients were invited to participate in this long term study and to provide an additional blood sample at least four months after surgery. This time period corresponds to around six half-lives of serum IgG. After this time period more than 98% of the antibodies generated perioperatively should have been degraded. This allows assessment of the longterm effects of CPB surgery on the B cell response.
The study was approved by the Ethics Committee of the Ernst-Moritz-Arndt University in Greifswald,
Germany.
A n t i b o d y a s s a y s a n d C R P -m e a s u r e m e n t
Anti-PF4/H-IgG antibodies were assessed by enzyme immunoassay (EIA) 26 and reactivities are given as optical densities (ODs). As several patients showed an OD > 0.5 in the baseline sample, we defined as responders patients experiencing an increase of the OD at day 10 of ≥ 0.5 compared to the baseline OD values. Patients with a lower increase or no increase at all were classified as nonresponders.
Concentrations of anti-DT and anti-TT recall antibodies were measured using the SERION ELISA classic kit according to the manufacturer's instructions (Virion\Serion, Würzburg, Germany). The optical densities were compared with an approved standard and are given in international serum units (IU) . For the determination of IgM or IgG total serum concentrations, Nunc MaxiSorp® 96 well plates (NUNC, Langenselbold, Germany) were coated overnight at 4 °C with goat anti-human Ig (Southern Biotech, Birmingham, USA). After washing, free protein binding sites were blocked with 2% goat normal serum in PBS/Tween. Serum was diluted with the blocking buffer, added to the sample wells, and incubated for one hour. Bound antibodies were detected with goat anti-human IgM-HRPOD (Dianova, Hamburg, Germany) or goat anti-human IgG-HRPOD (Dianova, Hamburg, Germany). The plates were developed with BD OptEIA™ TMB Substrate Reagent, stopped with 2 N H 2 SO 4 and read at 450 nm. Concentrations were determined with an appropriate standard curve. 
Results
In total, 166 patients were enrolled in this long-term study. As expected, CPB surgery induced a strong inflammatory response. The patients' maximal CRP serum concentrations three days after surgery averaged 167 mg/dl (range: 3 mg/dl -350 mg/dl; reference value for healthy controls < 1 mg/dl) (Figure 1 ). The CRP concentrations on day three (maximum) did not correlate with the increases of total or antigen-specific IgG concentrations described below ( Figure S1 ).
Kinetics of the anti-PF4/H response
Anti-PF4/H IgG increased by at least 0.5 OD by day 10 after surgery in 72 patients (responders; Figure 2A ). When these patients were re-assayed at > 4 months, anti-PF4/H ODs had decreased and responders became indistinguishable from nonresponders ( Figure 2B) fitting earlier observations of a transient nature of the anti-PF4/H antibody response. 8, 14, 27 Ninety-four patients were nonresponders (ΔOD < 0.5; Figure 2A ).
Kinetics of autoreactive antibodies
In contrast to the rapid transient increase in anti-PF4/H IgG, serum antibody binding to typical autoantigens did not change after CPB surgery. When we screened the sera for anti-cellular antibodies using binding to HEp2 cells as a readout, the majority of patients, 124 out of 166 (74.7%), did not show any sign of autoreactivity during the entire study period ( Figure 3A) ; 22 patients had weakly binding IgG autoantibodies (not shown), and 20 patients exhibited strong IgG binding with typical patterns of autoreactivity ( Figure 3B , C). In the patients with autoreactive antibodies, these antibodies were already present in the baseline sample taken before surgery. Neither the pattern nor the binding intensities of these IgG autoantibodies changed during the postsurgical period. This renders it very unlikely that the anti-PF4/H antibody response is part of a general activation of autoreactive B cells. 
Polyclonal B cell activation
Total IgG serum concentration increased by a mean of 30% between baseline and day 10 after surgery (p<0.001; Table 1 ) and was even higher in the sample taken more than 4 months after surgery. Figure S2 ). This difference was due to those patients, whose baseline IgG concentration exceeded 15 mg/ml, which was the case in 21 responders and 5 nonresponders. The 26 patients maintained or even increased their very high IgG serum concentrations over the whole study period ( Figure S3 ). Yet neither the baseline IgG concentrations nor the changes in total IgG serum concentration correlated with the increase of anti-PF4/H ODs ( Figures S4 A and B) . Furthermore, the 26 patients with high baseline IgG concentrations did not differ from the others with regard to their general inflammatory response as determined by serum CRP concentrations at day 3 after surgery ( Figure S5 ).
The kinetic of total serum IgM concentrations was very similar to the changes in total serum IgG concentrations ( Figure S6 ).
We then focused on established B cell memory for the classical recall antigens TT and DT and measured a small but significant increase of IgG binding to these antigens over time (p<0.001 in both cases; Figure 5A ), with no difference between anti-PF4/H responders and nonresponders (TT: p >4mo-d0 =0.49; DT: p >4mo-d0 =0.35, Mann-Whitney-U test; Table 2 hypothesis is in line with the observation that anti-PF4/H IgG antibodies occurred in about half of the patients in the present study until day 6 23,24 and HIT typically occurs between days 5 and 10 after surgery. 24, 36, 37 These observations are difficult to reconcile with the notion of a primary immune response.
The immune response pattern after cardiac surgery has been studied previously. Two groups found a decrease of total IgG concentrations following CPB, which in the study of Lante and coworkers amounted to 30% on the first day after surgery. 38, 39 Considering the serum half-life of IgG, which is around 20 days, this rapid effect must be due to hemodilution and/or sequestration of IgG, 39 since changes in IgG production can account for a decrease of maximally 3% within one day.
Furthermore, memory B cells are highly responsive to polyclonal stimuli such as microbial products, CD40-ligation and common γ -chain cytokines. 19 It has been proposed that polyclonal activation regularly boosts humoral memory and contributes to its maintenance in the absence of cognate antigen. [19] [20] [21] [22] We therefore assessed whether CPB surgery and the associated inflammatory response led to an antigen-independent activation of B cells. For this we measured the total serum IgG concentrations as well as the response to two prototypic recall antigens, TT and DT. These antigens were selected because most individuals are vaccinated against these proteins and possess specific memory B cells as well as long-lived plasma cells, which maintain the constant serum antibody concentrations. 40 Obviously, there will be no antigen-driven reactivation of TT-or DT-specific memory B cells during CPB surgery.
IgG serum concentrations moderately increased over baseline by day 10 after surgery and continued to rise over the next months. This strongly indicates that cardiac surgery has long-term effects on antibody-producing plasma cells. Focussing on antigen-specific antibodies, Lante et al.
observed that the concentration of TT-binding IgG had moderately increased by day 5 after CPB surgery. 38 Our data corroborate and extend their observations showing that the increase was stable over several months and that anti-DT antibodies exhibit a similar behavior. Thus stimulation of antibody production to recall antigens appears to be a more general feature of CPB intervention, indicating that memory B cells are indeed polyclonally activated in major surgery patients.
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From If the antibody titers to DT and TT had shown a transient increase, similar to the kinetics of the PF4/H response, the latter could have been attributed to polyclonal activation of memory B cells, too. However, this was not the case, and thus the polyclonal activation of memory B cells cannot fully explain the anti-PF4/H IgG response to CPB surgery. Firstly, a continuous moderate increase characterized IgG binding to the "classical" recall antigens, whereas in many individuals, the anti-PF4/H response was strong, even dramatic initially. This strong initial increase can easily explained by antigen exposure. However, secondly, the PF4/H IgG titers declined and after 4 months there was no longer any difference between responders and nonresponders detectable. This is consistent with our previous findings that IgG + memory B cells with specificity for TT but not for PF4/H are found in the peripheral blood of CPB patients prior to surgery. 41 Furthermore, from the transience of its kinetics it is obvious that long-lived plasma cells do not readily develop during an anti-PF4/H response.
41
Finally, there is evidence that an anti-PF4/H immune response can be elicited in MyD88-knock-out mice, who are deficient in their response to many polyclonal B cell stimuli. 42 Taken together, the anti-PF4/H response shows a very different pattern compared with the polyclonal response to classic recall antigens. This suggests that the anti-PF4/H response is antigen-driven, which is likely since the immune system was challenged with heparin during and after surgery but not with DT and TT.
Besides polyclonal activation of B cells, for example via toll-like receptors, 19 also a shift in the T cell subset composition could contribute to alterations in the antibody response after major surgery. Tables   Table 1: IgG serum concentrations in the whole study group (A), nonresponders (B) and responders (C). Table 2 : Serum concentrations of IgG specific for DT and TT in the whole study group (A), antibodies at any time. The two patients, B and C, already had antibodies against nuclear or cytoplasmic antigens before surgery. These did not change in quality or quantity after surgery. Twenty out of the 166 patients showed a similar picture. and responder (C) groups. However, the mean value for IgG in nonresponders to PF4/H at baseline was lower than in responders. This was due to a larger proportion of individuals with total IgG levels >15 mg/mL (see also Figure S2 ). n = 166, ***: p < 0.001 Serum concentrations of antibodies binding to DT and TT were determined by ELISA before (d0), 10 days (d10) and more than four months (> 4 mo) after CPB. Friedman's test with Dunn's post test revealed a significant increase of the concentrations over time in the patient group as a whole (A). The increase was similar in nonresponders (B) and responders (C). Means are shown (solid lines). n = 166; *: p < 0.05, **: p < 0.01, ***: p < 0.001
nonresponders (B) and responders (C).
